Showing posts with label Cardiac Rhythm Management Devices market segmentation. Show all posts
Showing posts with label Cardiac Rhythm Management Devices market segmentation. Show all posts

Thursday, 28 April 2016

Cardiac Rhythm Management Devices Pipeline Review 2016 Market Outlook to 2021 Italy

GlobalData’s new report, "Italy Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the Italy Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers. In the past few decades, the use of cardiac rhythm management (CRM) devices has increased worldwide due to the increase in life expectancy and technological developments (e.g., cardiac resynchronization therapy) that have extended their indications (1,2,3,4). When imaging is required in patients with CRM devices, computed tomography (CT) is the preferred modality because magnetic resonance imaging has been generally contraindicated (5,6,7).The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.


The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the Italy Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Table of Contents

1Table of Contents 2
    1.1 List of Tables 4
    1.2 List of Figures 5
2 Introduction 6
    2.1 What Is This Report About? 6
    2.2 Cardiac Rhythm Management Devices Market Segmentation 6
    2.3 Definitions of Markets Covered in the Report 7
3 Cardiac Rhythm Management Devices Market, Italy 9 
    3.1 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2007-2014 9
    3.2 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2014-2021 11
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Pacemakers Market, Italy, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), by Segment, 2014-2021 19
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), by Segment, 2014-2021 21
      3.2.6 Pacemakers Market, Italy, Revenue ($m), by Segment, 2014-2021 23
    3.3 Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2007-2014 25
    3.4 Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2014-2021 27
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), by Segment, 2007-2014 29
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), by Segment, 2007-2014 31
      3.4.3 Pacemakers Market, Italy, Volume (Units), by Segment, 2007-2014 33
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), by Segment, 2014-2021 35
      3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), by Segment, 2014-2021 37
      3.4.6 Pacemakers Market, Italy, Volume (Units), by Segment, 2014-2021 39
    3.5 Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2007-2021 41
    3.6 Cardiac Rhythm Management Devices Market, Italy, Distribution Share by Revenue ($m), 2013-2014 43
    3.7 Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), 2014 44 


4 Overview of Key Companies in Italy, Cardiac Rhythm Management Devices Market 46
    4.1 Medtronic plc 46
      4.1.1 Company Overview 46
    4.2 St. Jude Medical, Inc. 46
      4.2.1 Company Overview 46
    4.3 Boston Scientific Corporation 46
      4.3.1 Company Overview 46
    4.4 Biotronik SE & Co. KG 47
      4.4.1 Company Overview 47
    4.5 Sorin S.p.A. (Inactive) 47
      4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Appendix 49
    6.1 Research Methodology 50
      6.1.1 Coverage 50
      6.1.2 Secondary Research 50
      6.1.3 Primary Research 51
      6.1.4 Market Modeling and Forecasting 52
      6.1.5 Company Share Analysis 55
      6.1.6 Distribution Share Analysis 56
    6.2 Expert Panel 57
    6.3 GlobalData Consulting 57
    6.4 Contact Us 57
    6.5 Disclaimer 57


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)




Germany Cardiac Rhythm Management Devices Pipeline Review 2016 Market Outlook to 2021

Summary

GlobalData’s new report, "Germany Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the Germany Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers. In the past few decades, the use of cardiac rhythm management (CRM) devices has increased worldwide due to the increase in life expectancy and technological developments (e.g., cardiac resynchronization therapy) that have extended their indications (1,2,3,4). The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Complete report details @

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the Germany Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Table of Contents
1 Table of Contents 2
    1.1 List of Tables 4
    1.2 List of Figures 5
2 Introduction 6
    2.1 What Is This Report About? 6
    2.2 Cardiac Rhythm Management Devices Market Segmentation 6
    2.3 Definitions of Markets Covered in the Report 7
3 Cardiac Rhythm Management Devices Market, Germany 9
    3.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2007-2014 9
    3.2 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2014-2021 11
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2014-2021 19
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2014-2021 21
      3.2.6 Pacemakers Market, Germany, Revenue ($m), by Segment, 2014-2021 23
    3.3 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2007-2014 25
    3.4 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2014-2021 27
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2007-2014 29
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2007-2014 31
      3.4.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2007-2014 33
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2014-2021 35
      3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2014-2021 37
      3.4.6 Pacemakers Market, Germany, Volume (Units), by Segment, 2014-2021 39
    3.5 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2007-2021 41
    3.6 Cardiac Rhythm Management Devices Market, Germany, Distribution Share by Revenue ($m), 2013-2014 43
    3.7 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2014 44 

4 Overview of Key Companies in Germany, Cardiac Rhythm Management Devices Market 46
    4.1 Medtronic plc 46
      4.1.1 Company Overview 46
    4.2 St. Jude Medical, Inc. 46
      4.2.1 Company Overview 46
    4.3 Boston Scientific Corporation 46
      4.3.1 Company Overview 46
    4.4 Biotronik SE & Co. KG 47
      4.4.1 Company Overview 47
    4.5 Sorin S.p.A. (Inactive) 47
      4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Recent Developments 49
    6.1 Corporate Communications 49
      6.1.1 Nov 16, 2015: Konica Minolta to Start In Vitro Diagnostics Business in European and American Markets: SPFS Immunoassay System on Reference Exhibit at MEDICA 2015 in Germany 49
    6.2 Other Significant Developments 50
      6.2.1 Dec 04, 2015: BIOTRONIK and Cardiology Experts Support Heartbeat International in Top Education 50
      6.2.2 Feb 19, 2015: Helius Medical Enrols First Patients In Multiple Sclerosis Feasibility Trial Of PoNS Device 51 

  6.3 Product News 52
      6.3.1 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 52
    6.4 Strategy And Business Planning 53
      6.4.1 May 14, 2015: Merrimack Pharmaceuticals Announces Presentations on MM-398 at the 2015 American Society of Clinical Oncology Annual Meeting 53
7 Appendix 55
    7.1 Research Methodology 56
      7.1.1 Coverage 56
      7.1.2 Secondary Research 56
      7.1.3 Primary Research 57
      7.1.4 Market Modeling and Forecasting 58
      7.1.5 Company Share Analysis 61
      7.1.6 Distribution Share Analysis 62
    7.2 Expert Panel 63
    7.3 GlobalData Consulting 63
    7.4 Contact Us 63
    7.5 Disclaimer 63


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)



France Cardiac Rhythm Management Devices Pipeline Review 2016 Market Outlook to

GlobalData’s new report, "France Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the France Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers. In the past few decades, the use of cardiac rhythm management (CRM) devices has increased worldwide due to the increase in life expectancy and technological developments (e.g., cardiac resynchronization therapy) that have extended their indications (1,2,3,4). When imaging is required in patients with CRM devices, computed tomography (CT) is the preferred modality because magnetic resonance imaging has been generally contraindicated (5,6,7).The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.


The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the France Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Table of Contents

1Table of Contents 2
    1.1 List of Tables 4
    1.2 List of Figures 5
2 Introduction 6
    2.1 What Is This Report About? 6
    2.2 Cardiac Rhythm Management Devices Market Segmentation 6
    2.3 Definitions of Markets Covered in the Report 7
3 Cardiac Rhythm Management Devices Market, France 9 
    3.1 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2007-2014 9
    3.2 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2014-2021 11
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Pacemakers Market, France, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), by Segment, 2014-2021 19
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), by Segment, 2014-2021 21
      3.2.6 Pacemakers Market, France, Revenue ($m), by Segment, 2014-2021 23
    3.3 Cardiac Rhythm Management Devices Market, France, Volume (Units), 2007-2014 25
    3.4 Cardiac Rhythm Management Devices Market, France, Volume (Units), 2014-2021 27
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), by Segment, 2007-2014 29
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), by Segment, 2007-2014 31
      3.4.3 Pacemakers Market, France, Volume (Units), by Segment, 2007-2014 33
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), by Segment, 2014-2021 35
      3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), by Segment, 2014-2021 37
      3.4.6 Pacemakers Market, France, Volume (Units), by Segment, 2014-2021 39
    3.5 Cardiac Rhythm Management Devices Market, France, Average Price ($), 2007-2021 41
    3.6 Cardiac Rhythm Management Devices Market, France, Distribution Share by Revenue ($m), 2013-2014 43
    3.7 Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), 2014 44 


4 Overview of Key Companies in France, Cardiac Rhythm Management Devices Market 46
    4.1 Medtronic plc 46
      4.1.1 Company Overview 46
    4.2 St. Jude Medical, Inc. 46
      4.2.1 Company Overview 46
    4.3 Boston Scientific Corporation 46
      4.3.1 Company Overview 46
    4.4 Biotronik SE & Co. KG 47
      4.4.1 Company Overview 47
    4.5 Sorin S.p.A. (Inactive) 47
      4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Appendix 49
    6.1 Research Methodology 50
      6.1.1 Coverage 50
      6.1.2 Secondary Research 50
      6.1.3 Primary Research 51
      6.1.4 Market Modeling and Forecasting 52
      6.1.5 Company Share Analysis 55
      6.1.6 Distribution Share Analysis 56
    6.2 Expert Panel 57
    6.3 GlobalData Consulting 57
    6.4 Contact Us 57
    6.5 Disclaimer 57


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)



Wednesday, 27 April 2016

Cardiac Rhythm Management Devices Market Parameters 2007-2021 United Kingdom

Summary

GlobalData’s new report, "United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United Kingdom Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.



Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the United Kingdom Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.


Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents 

1 Table of Contents 2
    1.1 List of Tables 4
    1.2 List of Figures 5
2 Introduction 6
    2.1 What Is This Report About? 6
    2.2 Cardiac Rhythm Management Devices Market Segmentation 6
    2.3 Definitions of Markets Covered in the Report 7 

Make an enquiry before buying this Report @

3 Cardiac Rhythm Management Devices Market, United Kingdom 9
    3.1 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2007-2014 9
    3.2 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2014-2021 11
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 13
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 15
      3.2.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 17
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 19
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 21
      3.2.6 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 23
    3.3 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2007-2014 25
    3.4 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2014-2021 27
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2007-2014 29
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2007-2014 31
      3.4.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2007-2014 33
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2014-2021 35
      3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2014-2021 37
      3.4.6 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2014-2021 39
    3.5 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2007-2021 41
    3.6 Cardiac Rhythm Management Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 43
    3.7 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2014 44 


4 Overview of Key Companies in United Kingdom, Cardiac Rhythm Management Devices Market 46 
    4.1 Medtronic plc 46
      4.1.1 Company Overview 46
    4.2 St. Jude Medical, Inc. 46
      4.2.1 Company Overview 46
    4.3 Boston Scientific Corporation 46
      4.3.1 Company Overview 46
    4.4 Biotronik SE & Co. KG 47
      4.4.1 Company Overview 47
    4.5 Sorin S.p.A. (Inactive) 47
      4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Financial Deals Landscape 49

    6.1 Acquisition 49
      6.1.1 Mittel Plans to Sell 6% Interest in LivaNova 49
7 Recent Developments 50
    7.1 Financial Announcements 50
      7.1.1 Nov 12, 2015: LivaNova Provides Business Update 50
    7.2 Legal And Regulatory 52
      7.2.1 Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter 52
8 Appendix 54
    8.1 Research Methodology 55
      8.1.1 Coverage 55
      8.1.2 Secondary Research 55
      8.1.3 Primary Research 56
      8.1.4 Market Modeling and Forecasting 57
      8.1.5 Company Share Analysis 60
      8.1.6 Distribution Share Analysis 61
    8.2 Expert Panel 62
    8.3 GlobalData Consulting 62
    8.4 Contact Us 62
    8.5 Disclaimer 62


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Cardiac Rhythm Management Devices Market Forecast 2007-2021 United States

Summary
GlobalData’s new report, "United States Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.


Scope
- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


Table of Contents
1 Table of Contents 2
    1.1 List of Tables 6
    1.2 List of Figures 7
2 Introduction 8
    2.1 What Is This Report About? 8
    2.2 Cardiac Rhythm Management Devices Market Segmentation 8
    2.3 Definitions of Markets Covered in the Report 9
3 Cardiac Rhythm Management Devices Market, United States 11
    3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2007-2014 11
    3.2 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2014-2021 13
      3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2007-2014 15
      3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2007-2014 17
      3.2.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2007-2014 19
      3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2014-2021 21
      3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2014-2021 23
      3.2.6 Pacemakers Market, United States, Revenue ($m), by Segment, 2014-2021 25
    3.3 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2007-2014 27
    3.4 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2014-2021 29
      3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2007-2014 31
      3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2007-2014 33
      3.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2007-2014 35
      3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2014-2021 37 

 

     3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2014-2021 39
      3.4.6 Pacemakers Market, United States, Volume (Units), by Segment, 2014-2021 41
    3.5 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2007-2021 43
    3.6 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014 45
    3.7 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2014 46
4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market 48
    4.1 Medtronic plc 48
      4.1.1 Company Overview 48
    4.2 St. Jude Medical, Inc. 48
      4.2.1 Company Overview 48
    4.3 Boston Scientific Corporation 48
      4.3.1 Company Overview 48
    4.4 Biotronik SE & Co. KG 49 


      4.4.1 Company Overview 49
5 Cardiac Rhythm Management Devices Market Pipeline Products 50
6 Financial Deals Landscape 51
    6.1 Equity Offerings 51
      6.1.1 Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units 51
      6.1.2 Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 53
    6.2 Venture Financing 55
      6.2.1 EBR Systems Raises USD20 Million in Venture Financing
55 


Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)